E Fund Management’s ResMed RMD Stock Holding History

E Fund Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$402K	Buy	2,064 +197	+11%	+$40.8K	0.01%	324
2026 Q1	$419K	Buy	+1,867	New	+$465K	0.01%	322
2025 Q2	$369K	Sell	1,432 -287	-17%	-$68.5K	0.02%	270
2025 Q1	$385K	Buy	1,719 +47	+3%	+$11K	0.02%	255
2024 Q4	$382K	Buy	1,672 +718	+75%	+$173K	0.02%	264
2024 Q3	$233K	Buy	+954	New	+$213K	0.01%	295
2024 Q2	–	Sell	-1,177	Closed	-$233K	–	367
2024 Q1	$233K	Buy	+1,177	New	+$216K	0.01%	317
2022 Q1	–	Sell	-787	Closed	-$205K	–	352
2021 Q4	$205K	Buy	+787	New	+$204K	0.01%	258

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

E Fund Management's RMD Position: Q2 2026 in Review

E Fund Management increased its ResMed (RMD) stake by 11% in Q2 2026, buying an estimated $40.8K and bringing the position to 2,064 shares worth $402K. The position accounts for 0.01% of the portfolio, ranked #324.

E Fund Management first reported a position in RMD in Q4 2021 and has held it in 8 quarters since. The position peaked at $419K in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

E Fund Management held 2,064 shares of ResMed worth $402K as of Q2 2026.
E Fund Management bought 197 ResMed shares in Q2 2026, an estimated $40.8K.
ResMed made up 0.01% of E Fund Management's portfolio in Q2 2026, its #324 holding.
E Fund Management first reported a position in ResMed in Q4 2021 and has held it in 8 quarters since.
E Fund Management's ResMed position peaked at $419K in Q1 2026.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on E Fund Management's 13F filing for Q2 2026, filed 11 Aug 2026.